Dipeptidyl peptidase inhibitor PT-100 suppresses tumor growth in vivo and enhances chemotherapy in mice.

被引：0

作者：

Adams, S ^{[1
]}

Miller, GT ^{[1
]}

Jones, B ^{[1
]}

机构：

[1] Point Therapeut Inc, Boston, MA USA

来源：

CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6229S / 6230S

页数：2

共 50 条

[21] The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients
Balas, Bogdan
Baig, Muhammad R.
Watson, Catherine
Dunning, Beth E.
Ligueros-Saylan, Monica
Wang, Yibin
He, Yan-Ling
Darland, Celia
Holst, Jens J.
Deacon, Carolyn F.
Cusi, Kenneth
Mari, Andrea
Foley, James E.
DeFronzo, Ralph A.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1249 - 1255
[22] GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo
Raab, Marc S.
Breitkreutz, Iris
Anderhub, Simon
Ronnest, Mads H.
Leber, Blanka
Larsen, Thomas O.
Weiz, Ludmila
Konotop, Gleb
Hayden, Patrick J.
Podar, Klaus
Fruehauf, Johannes
Nissen, Felix
Mier, Walter
Haberkorn, Uwe
Ho, Anthony D.
Goldschmidt, Hartmut
Anderson, Kenneth C.
Clausen, Mads H.
Kraemer, Alwin
CANCER RESEARCH, 2012, 72 (20) : 5374 - 5385
[23] Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer
Bei Zuo
Tao Li
Xiaoyun Liu
Shuling Wang
Jianxiang Cheng
Xiangqun Liu
Wenjie Cui
Hengliang Shi
Chunhua Ling
Clinical and Translational Oncology, 2023, 25 : 3188 - 3202
[24] Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer
Zuo, Bei
Li, Tao
Liu, Xiaoyun
Wang, Shuling
Cheng, Jianxiang
Liu, Xiangqun
Cui, Wenjie
Shi, Hengliang
Ling, Chunhua
CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (11): : 3188 - 3202
[25] VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo
Zhai, YF
Ni, J
Jiang, GW
Lu, JM
Xing, LL
Lincoln, C
Carter, KC
Janat, F
Kozak, D
Xu, SM
Rojas, L
Aggarwal, BB
Ruben, S
Li, LY
Gentz, R
Yu, GL
FASEB JOURNAL, 1999, 13 (01): : 181 - 189
[26] Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo
Chen, Zhenghu
Zhao, Yanling
Yu, Yang
Pang, Jonathan C.
Woodfield, Sarah E.
Tao, Ling
Guan, Shan
Zhang, Huiyuan
Bieerkehazhi, Shayahati
Shi, Yan
Patel, Roma
Vasudevan, Sanjeev A.
Yi, Joanna S.
Muscal, Jodi A.
Xu, Guo-Tong
Yang, Jianhua
ONCOTARGET, 2017, 8 (61) : 104090 - 104103
[27] Exercise, alone and in combination with an anti-CEA vaccine, reduces pancreatic tumor cell growth and enhances survival in mice.
Rogers, Connie
Hance, Kenneth
Zaharoff, David
Perkins, Susan
Hursting, Stephen
Schlom, Jeffrey
Greiner, John
CANCER RESEARCH, 2008, 68 (09)
[28] Bone marrow-derived cells contribute to tumor neovasculature and when modified to express an angiogenesis inhibitor, restrict tumor growth in mice.
Davidoff, AM
Leary, R
Ng, CYC
Spurbeck, W
Brown, P
Horwitz, EM
Nienhuis, AW
Vanin, EF
BLOOD, 2000, 96 (11) : 804A - 804A
[29] Schisandrin B suppresses gastric cancer cell growth and enhances the efficacy of chemotherapy drug 5-FU in vitro and in vivo
He, Leye
Chen, Hao
Qi, Qinqin
Wu, Nan
Wang, Ying
Chen, Mengxia
Feng, Qian
Dong, Buyuan
Jin, Rong
Jiang, Lei
EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 920
[30] DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice
Matsumoto, G
Rahman, MA
Muta, M
Nakamura, T
Bando, H
Saji, S
Tsuruta, K
Okamoto, A
Toi, M
ONCOLOGY REPORTS, 2004, 12 (02) : 281 - 285

← 1 2 3 4 5 →